Form 4: Emergent BioSolutions Executive Reports Stock Transaction
SEC Form 4 Filing
Coleen Glessner, EVP at Emergent BioSolutions, reports disposition of shares to cover tax obligations.
Summary
- On March 1, 2024, Coleen Glessner, an Executive Vice President at Emergent BioSolutions Inc., disposed of 381 shares of common stock to cover tax obligations.
- The transaction was executed at a price of $3.39 per share.
- Following the transaction, Glessner directly owns 164,968 shares of Emergent BioSolutions Inc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates that an executive disposed of shares to cover tax obligations, which is a common practice.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of stock transaction (disposal of shares). |
| 03/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.